Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
WHO calls for urgent expansion of newborn screening to prevent 8 million annual birth defects
The World Health Organization has released a major report calling on countries to expand newborn…
The Sandwich Generation: When Adult Children Become Caregivers for Aging Parents
Adult children caring for aging parents often resist naming this role, but early recognition of…
Medicare’s AI Prior Authorization System Creates Patient Care Delays, Doctors Report
Medicare's pilot programme using artificial intelligence to automate prior authorisation decisions is generating significant delays…
How to Spot and Debunk Vaccine Misinformation: A Journalist’s Toolkit From PAHO
The Pan American Health Organization (PAHO) has published practical guidance for journalists to identify and…
Kenya launches ambitious strategy to manufacture its own vaccines and health products
Kenya has adopted a comprehensive strategy to manufacture vaccines and health products locally through 2030,…